Simple assay based on restriction fragment length polymorphism associated with IL28B in chronic hepatitis C patients

References

• Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. Hepatology 1997;26:34S–8S.
   PubMed Web of Science ®Google Scholar
• Aytaman A, Kaufman M, Terrault NA. Management of posttransplant hepatitis C infection. Curr Opin Organ Transplant 2010;15:301–9.
   PubMed Web of Science ®Google Scholar
• Hoofnagle JH, Seeff LB. Peginterferon and ribavirin for chronic hepatitis C. N Engl J Med 2006;355:2444–51.
   PubMed Web of Science ®Google Scholar
• Kanda T, Imazeki F, Yonemitsu Y, Mikami S, Takada N, Nishino T, Quantification of hepatitis C virus in patients treated with peginterferon-alfa 2a plus ribavirin treatment by COBAS TaqMan HCV test. J Viral Hepat 2010; Epub ahead of print.
   Google Scholar
• Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001;409:928–33.
   PubMed Web of Science ®Google Scholar
• Xing J, Watkins WS, Witherspoon DJ, Zhang Y, Guthery SL, Thara R, Fine-scaled human genetic structure revealed by SNP microarrays. Genome Res 2009;19:815–25.
   PubMed Web of Science ®Google Scholar
• Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009;461:399–401.
   PubMed Web of Science ®Google Scholar
• Yokosuka O, Ikeuchi T, Kanda T, Kawai S, Imazeki F, Saisho H, The prevalence of TT virus infection in renal transplant recipients in Brazil. Transplantation 2000;70:1194–7.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 2009;41:1105–9.
   PubMed Web of Science ®Google Scholar
• Rauch A, Kutalik Z, Descombes P, Cai T, Di luio J, Mueller T, Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010;138:1338–45.
   PubMed Web of Science ®Google Scholar
• Lindh M, Lagging M, Norkrans G, Hellstrand K. A model explaining the correlations between IL28B-related genotypes, hepatitis C virus genotypes, and viral RNA levels. Gastroenterology 2010;139:1794–6.
   PubMed Web of Science ®Google Scholar
• Imazeki F, Yokosuka O, Omata M. Impact of IL-28B SNPs on control of hepatitis C virus infection: a genome-wide association study. Expert Rev Anti Infect Ther 2010;8:497–9.
   PubMed Web of Science ®Google Scholar
• Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009;49:1335–74.
   PubMed Web of Science ®Google Scholar
• Kanda T, Imazeki F, Yokosuka O. New antiviral therapies for chronic hepatitis C. Hepatol Int 2010;4:548–61.
   PubMed Web of Science ®Google Scholar
• Kau A, Vermehren J, Sarrazin C. Treatment predictors of a sustained virologic response in hepatitis B and C. J Hepatol 2008;49:634–51.
   PubMed Web of Science ®Google Scholar
• Nakamoto S, Kanda T, Yonemitsu Y, Arai M, Fujiwara K, Fukai K, Quantification of hepatitis C amino acid substitutions 70 and 91 in the core coding region by real-time amplification refractory mutation system reverse transcription-polymerase chain reaction. Scand J Gastroenterol 2009;44:872–7.
   PubMed Web of Science ®Google Scholar
• Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 2009;41:1100–4.
   PubMed Web of Science ®Google Scholar
• Urban TJ, Thompson AJ, Bradrick SS, Fellay J, Schuppan D, Cronin KD, IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C. Hepatology 2010;52:1888–96.
   PubMed Web of Science ®Google Scholar
• Montes-Cano MA, Garcia-Lozano JR, Abad-Molina C, Romero-Gomez M, Barroso N, Aguilar-Reina J, Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes. Hepatology 2010;52:33–7.
   PubMed Web of Science ®Google Scholar
• Tillmann HL, Thompson AJ, Patel K, Wiese M, Tenckhoff H, Nischalke HD, A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice. Gastroenterology 2010;139:1586–92.
   PubMed Web of Science ®Google Scholar
• Galmozzi E, Menico BD, Rametta R, Dongiovanni P, Fracanzani AL, Benedan L, A tetra-primer amplification refractory mutation system polymerase chain reaction for the evaluation of rs12979860 IL28B genotype. J Viral Hepat 2010; Epub ahead of print.
   Google Scholar
• Akkarathamrongsin S, Sugiyama M, Matsuura K, Kurbanov F, Poovorawan Y, Tanaka Y, High sensitivity assay using serum sample for IL28B genotyping to predict treatment response in chronic hepatitis C patients. Hepatol Res 2010;40:956–62.
   PubMed Web of Science ®Google Scholar